Acrivon Therapeutics, Inc. (ACRV)
Nasdaq: ACRV · Pharmaceutical Preparations · Watertown, MA · filing with the SEC since 2021
Who runs Acrivon Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Blume-Jensen Peter
President and CEO. First filing Nov 2022, latest Aug 27, 2026, 2 filings in all.
Officers reporting now
9
of 20 people with a filing in the last fifteen months
Directors reporting now
11
22 people on the record since 2022
Officerssales are open-market, Oct 26, 2025 to Oct 26, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Miller Mary | Chief Legal Officer | Sep 2023 | Oct 26, 2026 | 4 · $0.00 |
| Levin Michaela | Chief Business Officer | Aug 2026 | Sep 2, 2026 | none |
| Blume-Jensen Peter | President and CEO | Nov 2022 | Aug 27, 2026 | 1 · $0.00 |
| Masson Kristina | EVP - Business Operations | Nov 2022 | Aug 27, 2026 | 2 · $0.00 |
| Devroe Eric | Chief Operating Officer | Nov 2022 | Aug 20, 2026 | 1 · $0.00 |
| Gamelin Erick | Chief Development Officer | Nov 2022 | Aug 20, 2026 | 1 · $0.00 |
| Peterson Katharine | Chief Accounting Officer | May 2024 | Aug 20, 2026 | 1 · $0.00 |
| Levy Adam D. | Chief Financial Officer | Apr 2025 | Aug 6, 2026 | 1 · $0.00 |
| Mirza Mansoor Raza | Chief Medical Officer | Apr 2025 | May 20, 2026 | none |
Directorssales are open-market, Oct 26, 2025 to Oct 26, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Baum Charles M | director | Jun 2023 | Jun 22, 2026 | none |
| Dirocco Derek | director | Nov 2022 | Jun 22, 2026 | none |
| Kolchinsky Peter | director | Nov 2022 | Jun 22, 2026 | none |
| Magovcevic-Liebisch Ivana | director | Feb 2024 | Jun 22, 2026 | none |
| Palani Santhosh | director | Mar 2024 | Jun 22, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Nov 2022 | Jun 22, 2026 | none |
| Ra Capital Management, L.P. | director | Nov 2022 | Jun 22, 2026 | none |
| Ra Capital Nexus Fund II, L.P. | director | Nov 2022 | Jun 22, 2026 | none |
| Shacham Sharon | director | Nov 2022 | Jun 22, 2026 | none |
| Shah Rajeev M. | director | Nov 2022 | Jun 22, 2026 | none |
| Tomsicek Michael John | director | Nov 2022 | Jun 22, 2026 | none |
Earlier names on the record11, newest filing first
Edelman Joseph · 10% owner · last filing May 2025Perceptive Advisors LLC · 10% owner · last filing May 2025Perceptive Life Sciences Master Fund Ltd · 10% owner · last filing May 2025Holm-Jorgensen Rasmus · officer · last filing Mar 2025Cuillerot Jean-Marie · officer · last filing Mar 2025Chione Ltd · 10% owner · last filing Jun 2023Czernik Marcin · 10% owner · last filing Jun 2023Hadjimichael Andreas · 10% owner · last filing Jun 2023Nikolaou Anastasis · 10% owner · last filing Jun 2023Smolokowski Wiaczeslaw · 10% owner · last filing Jun 2023Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · 10% owner · last filing Nov 2022
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.